Scientific Advisory Board
Last updated on 15 February 2024
Remit
The Scientific Advisory Board gives its opinion on the major orientations of our agency’s scientific strategy and on its activities. It also provides a forward-looking approach and reports on the work undertaken. This body helps to coordinate the efforts of its members in preparing for and responding to crises linked to emerging diseases, at scientific, industrial and public action levels.
It brings together 19 French and international scientific figures, as well as three representatives from the voluntary sector. Members are appointed for a four-year term by the Advisory Board on the recommendation of the agency Director.
Chair
Prof. Sharon Lewin
University of Melbourne, The Doherty Institute, Australia
Members
Fareed Abdullah
(South African Medical Research Council, Steve Biko Academic Hospital, South African TB Think Tank, South Africa)
Dominique Costagliola
(Inserm, Pierre Louis Institute of Epidemiology and Public Health, France )
Meg Doherty
(World Health Organization, Switzerland)
Daniel Douek
(Vaccine Research Center, NIAID/NIH, USA)
Diana Finzi
(Division of AIDS NIAID/NIH, USA)
Peter Horby
(Pandemic Sciences Centre, ISARIC, UK)
Marion Koopmans
(Erasmus MC, Netherlands)
Gabriel Leung
(Hong Kong University, Hong-Kong )
Seng Gee Lim
(National University Health System, Singapore)
Anna Lok
(University of Michigan Medical School, USA)
Ester Sabino
(University of São Paulo, Brazil)
Rodolphe Thiebaut
(Bordeaux Population Health – Inserm Unit 1219, Bordeaux University Hospital, University of Bordeaux, France )
Robert Thimme
(Medical Center – University of Freiburg, Germany)
Sylvie van der Werf
(Institut Pasteur, University of Paris, France)
Scott C. Weaver
(University of Texas Medical Branch, Galveston National Laboratory, USA)
Fabien Zoulim
(Hospices Civils de Lyon, Inserm Unité 1052, Cancer Research Centre of Lyon, France )
Véronique Deret
(SOS Hépatites, France)
Hugues Fischer
Lucas Vallet